Ozon Pharmaceuticals' net profit under IFRS for 9 months of 2025 amounted to 3.5 billion rubles, an increase of 52.2% compared to 2.3 billion rubles in the previous year. Revenue increased by 27.4% to ₽21.4 billion from ₽16.8 billion a year earlier.